DaVita Inc. (NYSE:DVA) Short Interest Update

DaVita Inc. (NYSE:DVA) saw a significant growth in short interest in January. As of January 15th, there was short interest totalling 4,410,000 shares, a growth of 9.2% from the December 31st total of 4,040,000 shares. Based on an average trading volume of 762,200 shares, the short-interest ratio is presently 5.8 days. Currently, 5.6% of the company’s stock are sold short.

Institutional Investors Weigh In On DaVita

Several hedge funds have recently modified their holdings of DVA. Transcendent Capital Group LLC acquired a new position in DaVita during the 3rd quarter valued at approximately $25,000. Blue Trust Inc. increased its stake in shares of DaVita by 56.4% in the third quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after acquiring an additional 119 shares during the period. Quarry LP acquired a new stake in shares of DaVita in the third quarter worth $60,000. Venturi Wealth Management LLC increased its stake in shares of DaVita by 59.8% in the fourth quarter. Venturi Wealth Management LLC now owns 406 shares of the company’s stock worth $61,000 after acquiring an additional 152 shares during the period. Finally, Versant Capital Management Inc increased its stake in shares of DaVita by 58.7% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after acquiring an additional 169 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Barclays raised their price target on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a research report on Thursday, October 31st. Truist Financial lifted their target price on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $161.80.

DaVita Price Performance

DaVita stock opened at $176.93 on Tuesday. The stock has a market cap of $14.51 billion, a price-to-earnings ratio of 19.09, a price-to-earnings-growth ratio of 0.86 and a beta of 0.93. The company has a debt-to-equity ratio of 15.78, a current ratio of 1.37 and a quick ratio of 1.33. DaVita has a 1 year low of $108.76 and a 1 year high of $179.60. The firm has a 50-day moving average of $159.91 and a two-hundred day moving average of $155.57.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.